Study 2018-53 (HTA) Immunoglobulin use

Ongoing study - This project aims at describing the current use and reimbursement of Immunoglobulins in Belgium, compared to other countries, and to critically assess, via a rapid review, the available evidence on their effectiveness and cost-effectiveness. 
The final goal is to draft recommendations for Immunoglobulins to be used and reimbursed in those indications in which they are most effective.  
 

 

Published on: 
2019/05/06